Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease

[1]  G. Tognoni,et al.  Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. , 1996, Archives of internal medicine.

[2]  R. Beaglehole,et al.  Evidence-based management of dyslipidaemia , 1995, The Lancet.

[3]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[4]  D. Kromhout,et al.  Total cholesterol concentration and mortality at a relatively young age: Do men and women differ? , 1995, BMJ.

[5]  A. Simon,et al.  Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men. Association with coronary risk profile. , 1995, Circulation.

[6]  P. Poole‐Wilson,et al.  Lower patients' cholesterol now , 1995, BMJ.

[7]  R. Platt,et al.  Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? , 1995, The New England journal of medicine.

[8]  M. Abrahamowicz,et al.  Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.

[9]  H. Krumholz,et al.  Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. , 1994, JAMA.

[10]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[11]  D. Gray,et al.  Value of screening for secondary causes of hyperlipidaemia in general practice , 1994, BMJ.

[12]  L. Wilkins.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .

[13]  N J Wald,et al.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.

[14]  J. Swales.  Textbook of hypertension , 1994 .

[15]  P Barham,et al.  Management of raised blood pressure in New Zealand: a discussion document. , 1993, BMJ.

[16]  F. Song,et al.  Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.

[17]  C. Bulpitt,et al.  Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. , 1993, BMJ.

[18]  Clyne,et al.  Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. , 1993, Journal of hypertension.

[19]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[20]  L. Ramsay,et al.  Dietary reduction of serum cholesterol concentration: time to think again. , 1991, BMJ.

[21]  H Tunstall-Pedoe,et al.  The Dundee coronary risk-disk for management of change in risk factors. , 1991, BMJ.

[22]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[23]  I. Holme,et al.  An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. , 1990, Circulation.

[24]  K. Matthews,et al.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. , 1990, BMJ.

[25]  S. Pocock,et al.  The variability of serum cholesterol measurements: implications for screening and monitoring. , 1990, Journal of clinical epidemiology.

[26]  J. Huttunen,et al.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. , 1988, JAMA.

[27]  B. Lewis,et al.  Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain , 1988, British medical journal.

[28]  S. Pocock,et al.  Identifying men at high risk of heart attacks: strategy for use in general practice. , 1986, British medical journal.

[29]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[30]  W. Kannel,et al.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. , 2020, Annals of internal medicine.